Objective: Among people with HIV, there are few long-term studies of noninvasive ultrasound-based measurements of the carotid artery predicting major health events. We hypothesized that such measurements are associated with 10-year mortality in the Women's Interagency HIV Study (WIHS) and Multicenter AIDS Cohort Study (MACS), and that associations differ by HIV serostatus.
Introduction
B-mode ultrasound-based measures of the carotid artery predict future risk of cardiovascular disease (CVD) and all-cause mortality in the general population [1, 2] . Carotid artery ultrasound can be used to image noninvasively various stages of arteriosclerosis, including arterial stiffening, wall thickening, plaque formation, and luminal narrowing, before cerebrovascular and cardiac disease manifest clinically [3, 4] . These measures are also used to characterize subclinical CVD burden in people living with HIV, a population with increased risks of myocardial infarction (MI) [5] , stroke [6] , heart failure [7] , and CVD mortality [8] , as well as a preponderance of CVD risk factors [9, 10] .
Different features of subclinical CVD have been found to have variable correlations in populations and also have independent associations with CVD risk [11] [12] [13] [14] [15] . In addition, metabolic variables and other CVD risk factors vary in their strengths of association with different arterial features, suggesting that multiple pathways studied through imaging may be responsible for disease [16] . Furthermore, elevated levels of immune activation, inflammation, and coagulation attributable to HIV infection may lead to greater CVD risk [17, 18] , but few studies of people with HIV have corroborated findings in the general population linking subclinical carotid artery disease measures with major health events. Therefore, we examined associations of three carotid artery ultrasound measurements -common carotid artery intima-media thickness (CCA-IMT), presence of plaque, and arterial stiffness -with all-cause and non-AIDS mortality over 10 years in the Women's Interagency HIV Study (WIHS) and Multicenter AIDS Cohort Study (MACS). We hypothesized that more subclinical disease would be associated with poorer survival, and that associations would differ by HIV serostatus.
Methods

Setting and participants
We conducted a nested cohort study within the female WIHS and the male MACS cohorts, two prospective multicenter studies of individuals with or at risk for HIV infection [19, 20] . Each cohort involves semiannual follow-up visits with detailed examinations, specimen collection, and structured interviews (Supplement, http://links.lww.com/QAD/B337). WIHS and MACS participants enrolled in a vascular substudy beginning in 2004 [21, 22] . The primary substudy exclusion criterion in MACS was self-reported history of coronary heart disease, including angina, MI, or coronary revascularization; this exclusion was not implemented in WIHS but was applied to this analysis. All individuals provided informed consent, and studies were approved by each site's Institutional Review Board.
Carotid artery data
Most participants attended a baseline substudy visit between 2004 and 2006. Some MACS men (29%) had their baseline visit between 2010 and 2013 [23] . All participants underwent high-resolution B-mode carotid artery ultrasound to image six locations in the right carotid artery according to published procedures [24] : the near and far walls of the common carotid artery, carotid bifurcation, and internal carotid artery. A standardized protocol was used at all sites [21] , and measurements were obtained at a centralized reading center.
Three carotid artery ultrasound parameters were selected for the current study because they are common noninvasive measurements of arteriosclerosis, and they have been associated with mortality in other populations [25, 26] . The first carotid artery ultrasound parameter was IMT measured in the far wall of the CCA. Mean CCA-IMT was assessed from standardized ultrasound images in a plaque-free area by automated computerized edge detection [27] . We choose to measure IMT at the CCA because this segment is almost always free from lesions. These measurements provide a 'clean' wall thickness measure, whereas measurements in other segments such as the internal carotid artery typically include IMT and lesion measurements combined. The second measure was presence of focal plaque, defined as an area with localized IMT more than 1.5 mm measured in at least one of the six aforementioned artery locations [28] . Lastly, Young's modulus of elasticity, an index of arterial stiffness [27] , was estimated in units of carotid diameter at diastole, and IMT D is CCA-IMT at diastole. Higher Young's modulus values indicate stiffer arteries. Coefficients of variation of CCA-IMT, carotid diameters, and blood pressures suggest high reproducibility [27] .
Outcomes
The primary outcome was all-cause mortality, ascertained using both active surveillance of participants and linkages with the National Death Index (NDI) [29] . For this analysis, the NDI was searched through 2014, except for two sites that completed searches through 2016. Participants were followed from the date of the baseline carotid scan to the earlier of the date of death or most recent NDI search (maximum 11.7 years).
A secondary outcome was death due to non-HIV-related causes (excluding external causes), based on the underlying cause of death derived from the death certificate. A non-HIV-related cause was defined as any death that did not include an International Classification of Diseases, 10th Revision (ICD-10) code for HIV disease as the underlying cause (B20-B24), with a further exclusion of deaths due to external causes including accidents, intentional self-harm, or assault (V01-Y89), or use of psychoactive substances (F11-F16, F18-F19) [30] ; this was done to focus on naturally occurring deaths. We did not examine CVD deaths separately, because death certificate data alone may be insufficient to determine cause and only a subset of deaths were adjudicated based on medical record review.
Other variables HIV infection was ascertained by ELISA and confirmed by Western blot. Potential confounders were measured at the core study visit closest in time to the baseline carotid scan [median time between core study visit and baseline carotid scan: 16 days, interquartile range (IQR) 1-57]. Demographic and behavioral confounders included age, self-reported race/ethnicity (black non-Hispanic, Hispanic, white non-Hispanic or other), education, income, study site, history of injection drug use, current crack/ cocaine and alcohol use, current smoking, and hepatitis C virus (HCV) infection. Cardiometabolic risk factors included BMI, SBP, total and HDL cholesterol, current use of antihypertensive and lipid-lowering medications, and diabetes mellitus. HIV-related variables included current CD4
þ T-lymphocyte cell count, current virologic suppression, current antiretroviral therapy (ART) use, and history of clinical AIDS. We also examined cumulative use of protease inhibitors and abacavir in sensitivity analyses, because some prior studies have reported associations with CVD risk [31, 32] .
Statistical methods
Within each cohort, we compared characteristics by HIV serostatus and examined Spearman correlations among ultrasound measurements. We determined death rates per 1000 person-years, age-standardized to the 2000 US Standard Population.
We constructed cumulative mortality curves by levels of each carotid measurement for a person aged 45 years, which was the average age at baseline. For time to allcause mortality, we used Cox regression to model the association with carotid measurements. For time to non-HIV mortality, we used competing risks regression to account for the competing risk of death due to HIV disease or external causes [33] . For both outcomes, we developed nested models to serially adjust for HIV serostatus, age, demographic and behavioral characteristics, cardiometabolic risk factors, and HIV-related factors. Because associations were qualitatively similar with each successively nested model, we report only the fully-adjusted results. We examined the three carotid measurements in separate models as well as simultaneously, to assess their isolated and independent associations with mortality.
Models were first developed within each cohort, and we combined cohorts when results were qualitatively similar. We ran stratified models among men and women, and among HIV-positive and negative participants, and assessed effect modification using two-way multiplicative interaction terms. Sensitivity analyses evaluated assumptions regarding study variables (Supplement, http:// links.lww.com/QAD/B337).
Analyses were conducted using R 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria), including the packages epitools, survival, and survminer. We determined statistical significance based on a two-sided P value less than 0.05. We used IVEware 0.3 (University of Michigan, Ann Arbor, Michigan, USA) to implement multiple imputation (five datasets) to account for less than 1% of values that we assumed were missing at random [34] .
Results
We studied 1722 women (71% HIV-positive) and 1304 men (62% HIV-positive), contributing 26 800 personyears of observation (Table 1) . Men were on average 10 years older than women at the baseline vascular study visit (median 50 versus 40). HIV-positive and negative groups were generally similar, although participants with HIV were more likely to have previously injected drugs and be coinfected with HCV. Among HIV-positive individuals, two-thirds reported using ART at baseline. Women were more likely to be nonwhite than men (90 versus 39%). Women were more likely to smoke and have higher BMI. Men had higher SBPs and total cholesterol and were more likely to be taking antihypertensive or lipid-lowering medications. (2) 7 (1) 193 (24) 184 (37) Behavior-related characteristics History of injection drug use (no., %) 323 (28) 98 (22) 127 (17) 38 (8) Current crack/cocaine use (no., %) 80 (7) 52 (11) 97 (13) 40 (8 433 (35) 219 (45) 426 (53) 250 ( 106 (9) 67 (14) 160 (20) 134 (27) Heavier (14þ drinks/week)
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77 (6) 8 (2) 226 (28) 111 ( Associations of carotid artery measures with allcause mortality We examined cumulative mortality in age-adjusted analyses stratified by cohort (Fig. 1) . For plaque and stiffness, a gradient was observed in which participants with more subclinical disease had greater mortality. Similar relationships were observed when we limited analyses to HIV-positive participants.
Successive adjustments for potential demographic, behavioral, cardiometabolic, and HIV-related confounders attenuated these findings (data not shown), but most relationships remained statistically significant despite control for these multiple risk factors. Table 2 shows the fully adjusted associations of each carotid artery measure with all-cause mortality in separate models. Differences by sex were assessed using a test for interaction (P < 0.05). Among men, having plaque at baseline was associated with a two-fold increased hazard of death (hazard ratio 2.19, 95% CI 1.41-3.43, P < 0.001), whereas this association was not apparent in women (hazard ratio 1.06, 95% CI 0.74-1.52, P ¼ 0.75; p for interaction 0.006). When we combined women and men, the association of plaque with all-cause mortality remained statistically significant (hazard ratio 1.44, 95% CI 1.10-1.88, P ¼ 0.007). We also found significant associations between Young's modulus and allcause mortality in women but not men. Women in the highest quartile had a 71% increased hazard of death compared with those in the lowest quartile (hazard ratio 1.71, 95% CI 1.11-2.61, P ¼ 0.01), whereas the same relationship was not apparent among men (hazard ratio 1.08, 95% CI 0.61-1.89, P ¼ 0.79; P for interaction 0.99). We did not observe an increase in all-cause mortality with greater CCA-IMT. Instead, individuals in the highest quartile of CCA-IMT appeared to have better survival than those in the lowest quartile (hazard ratio 0.71, 95% CI 0.48-1.05, P ¼ 0.08), with a statistically significant trend of lower mortality risk with increasing CCA-IMT (P ¼ 0.03). Including all three carotid artery ultrasound measurements in the same model resulted in similar associations.
When we stratified analyses by HIV serostatus, we found that associations limited to HIV-positive participants were similar to those in the combined analyses, with some significant associations becoming marginally significant ( Table 3 ). The ability of carotid artery ultrasound measures to predict death appeared to be stronger among HIV-negative than HIV-positive participants, although associations had wide CIs (Supplementary Table 2 , http://links.lww.com/QAD/B337). Accordingly, few of the relationships showed significant multiplicative effect modification by HIV serostatus. The exception was the association of plaque with mortality, which was significantly more pronounced in HIV-negative (hazard ratio 3.87, 95% CI 1.95-7.66, P < 0.001) compared with HIV-positive participants (hazard ratio 1.35, 95% CI 1.00-1.84, P ¼ 0.05) and showed evidence of both multiplicative (P < 0.001) and additive effect modification (data not shown).
Associations with non-HIV-related mortality
Because many deaths were due to HIV disease, we further examined associations of carotid artery measurements with mortality by limiting the analyses to naturally occurring non-HIV-related deaths (Table 4 ). In these analyses, which accounted for competing risks and excluded deaths due to HIV as well as external causes All models adjusted for HIV serostatus, age, race/ethnicity, education, income, study site, history of injection drug use, crack/cocaine use, smoking, alcohol, hepatitis C virus infection, BMI, SBP, total and HDL cholesterol, use of antihypertensive or cholesterol medications, diabetes, baseline CD4 þ T-cell count, antiretroviral therapy use, history of AIDS, and the other carotid artery measures. CCA-IMT, common carotid artery intimamedia thickness; CI, confidence interval; HR, hazard ratio; MACS, Multicenter AIDS Cohort Study; WIHS, Women's Interagency HIV Study. Bold text indicates P < 0.05.
(accidents, assaults, overdoses), associations of focal plaque with mortality were strengthened, with the hazard ratio among women and men combined increasing from 1.54 (95% CI 1.18-2.01) to 1.85 (95% CI 1.24-2.74). In women alone the hazard ratio increased from 1.20 to 1.51, while in men alone, the hazard ratio increased from 2.26 to 2.44. In contrast, associations of Young's modulus with mortality became negligible when focusing on non-HIV deaths.
Because of a statistically significant (P ¼ 0.01) interaction between plaque and HIV serostatus with respect to mortality, we performed analyses of naturally occurring deaths (excluding those due to HIV) stratified by HIV serostatus. Effect estimates had wide CIs due to more limited power. In analyses restricted to HIV-positive participants (Supplementary Table 3 
Discussion
We found that carotid artery plaque detected by B-mode ultrasound was independently associated with mortality in adults living with HIV who were free of clinical CVD. Subgroup analyses suggested that this association was stronger among the primarily white, highly educated male MACS cohort than the poorer, largely minority female WIHS cohort. Differences by cohort in the strength of associations between subclinical CVD and allcause mortality may be attributable to differences between cohorts in the distribution of causes of death, although we had limited ability to evaluate this due to incompleteness of cause on the death certificate. Nonetheless, it was notable that associations between carotid plaque and mortality were reproduced across two HIV-positive cohorts that are demographically very different, although studied using nearly identical methods. Arterial stiffness was also associated with mortality.
To our knowledge, ours is the first study to show that carotid artery plaque predicts mortality in adults with HIV. This is important because few studies to date have linked subclinical atherosclerosis with major health outcomes in HIV-positive people, although B-mode carotid artery ultrasound measurements are widely used markers of subclinical CVD. One electronic medical record-based study found that among 209 HIV-positive patients who underwent neck computed tomography with contrast, the presence of carotid plaque was associated with a three-to-four-fold increased risk of atherosclerotic CVD events and stroke [35] . In contrast, our analysis was conducted among persons free of clinical CVD and without a clinical indication for specialized imaging. This allowed for broader generalizability and assessment of preclinical disease indicators. Our key finding that HIV-positive individuals showed weaker associations between plaque and mortality, rather than stronger associations, warrants further investigation into the reasons for this disparity.
The association that we found between carotid artery plaque and mortality was also more pronounced in men than in women. It is unclear whether this is a consequence of differences in the underlying biology, differences in risk factor distributions, or a combination of the two. Although the cohorts vary by age, race/ ethnicity, socioeconomic status, and behavioral risk factors, we controlled extensively for these factors; nonetheless, there may be residual confounding. In support of a biological explanation, differences related to sex hormones, adaptive or innate immunity, and drug responses are increasingly postulated as modulators of carotid artery atherosclerosis and CVD risk in women versus men [36, 37] . The composition of plaques may differ between men and women, owing to differences in inflammatory and histologic features [38] [39] [40] . More detailed assessments of plaque are beyond the scope of the current article but may explain in part our results.
An unexpected finding was that greater CCA-IMT seemed to be associated with lower mortality risk, which was observed consistently in HIV-positive women and men. We cannot rule out survival bias as an explanation, as many study participants had lived with HIV for many years, and some with greater IMT could have died prior to this substudy. A pooled analysis of five cohorts (including WIHS and MACS) found that compared with HIV-negative individuals, CCA-IMT was lower among HIV-positive individuals even after confounder adjustment [41] . This finding was particularly noted among those not on ART with high levels of circulating HIV RNA. Thus, an emerging picture suggests that CCA-IMT may have a paradoxical association with disease in the context of HIV. We speculate that chronic arterial remodeling, altered metabolism, or other phenomena affecting the vasculature may account for the presence of thinned arterial walls among persons with long-standing HIV infection, as has been observed in patients with cancer and rheumatoid arthritis [42] [43] [44] .
Two smaller studies conducted among HIV-positive persons found significant associations between greater IMT and mortality. Mangili detected an association using IMT measured at the CCA [45] , while Hsu found an association using IMT measured at the internal carotid artery (ICA) but not at the CCA [46] . Variations in protocols may partially explain why these findings differ from ours. We limited CCA-IMT assessment to the far wall, where measurements are known to be more reproducible [47] , whereas Mangili assessed CCA-IMT at both the near and far walls. Although we defined plaque based on focal thickening more than 1.5 mm as measured in carotid sections including the ICA, we did not conduct a standardized assessment of plaque-free IMT in the ICA region.
We are not aware of studies linking arterial stiffness to mortality among HIV-positive persons. A meta-analysis of 10 non-HIV studies found that greater arterial stiffness was associated with a 22% increased risk of all-cause mortality [2] . Here, we found that women with greater arterial stiffness had higher mortality risk, but this association was not apparent in men. Although this finding is consistent with chance, it may suggest sex-based differences. The Multi-Ethnic Study of Atherosclerosis found that men and women had similar rates of change in Young's modulus over 10 years; however, a slower rate of increase over time associated with higher education level and lipid-lowering medication use was only observed among women [48] . In our study, women had lower education levels and were less likely to be receiving lipidlowering medication, suggesting that ongoing arterial stiffening related to these factors could have contributed to their higher mortality risk. Although our study was limited to baseline measurements of stiffness, examination of longitudinal patterns by sex may clarify whether disparities in disease management or other factors may contribute to the variation.
We believe that this is the largest study of health outcomes to date involving HIV-associated subclinical atherosclerosis. The analysis is nested within two well established cohorts that involve standardized longitudinal collection of HIV and non-HIV risk factors, with HIV-negative participants who are similar demographically and behaviorally to their HIV-positive counterparts. Another major strength is that women comprise over half of the study population. As a result, we were able to identify sexspecific differences that suggest potentially different underlying disease mechanisms. However, the men and women in our studies have distinct sociodemographic and behavioral profiles that likely contribute to broader mortality differences [29, 49] , and therefore more work is needed to disentangle these factors with respect to causespecific mortality. One limitation is that we did not have complete information on incident CVD events such as MI and stroke. Although the death certificate-based underlying cause of each death was recorded, we limited cause-specific analyses of mortality to non-HIV-related deaths as a category instead of a more focused group of CVD deaths, to avoid potential misclassification. Although we measured atherosclerosis via B-mode ultrasound, assessments in other arterial beds or via other modalities could provide additional prognostic information [12, 50, 51] . Finally, our study population was highly ART-experienced. Therefore, our findings may not be generalizable to more recently infected individuals.
Our study supports the validity of subclinical CVD markers to assess future health risks in HIV-positive adults. Our findings also suggest differences in mortality risk associated with atherosclerosis markers by HIV serostatus, across carotid artery features, and by sex that warrant further investigation into their underlying mechanisms. More specialized methods of analyzing the complex interactions that are present, such as machine learning, may be needed to help better isolate disease pathways and glean information from multiple vascular assessments [52] . This is especially true in the context of HIV infection, where existing CVD risk prediction equations may be inadequate [53] . Such work may help to identify appropriately tailored interventions to prevent and treat CVD in the growing number of people aging with HIV.
